Green-synthetized selenium nanoparticles using berberine as a promising anticancer agent.
10.1016/j.joim.2021.11.002
- Author:
Mohamed S OTHMAN
1
,
2
;
Sofian T OBEIDAT
3
;
Amal H AL-BAGAWI
4
;
Mohamed A FAREID
1
,
5
;
Alaa FEHAID
6
;
Ahmed E ABDEL MONEIM
7
Author Information
1. Basic Sciences Department, Deanship of Preparatory Year, University of Ha'il, Hail 2240, Saudi Arabia
2. Faculty of Biotechnology, October University for Modern Science and Arts, Giza 12451, Egypt. Electronic address: biostar55@yahoo.com.
3. Basic Sciences Department, Deanship of Preparatory Year, University of Ha'il, Hail 2240, Saudi Arabia.
4. Chemistry Department, Faculty of Science, University of Ha'il, Hail 2240, Saudi Arabia.
5. Department of Botany and Microbiology, Faculty of Science, Al-Azhar University, Cairo 35527, Egypt.
6. Forensic Medicine and Toxicology Department, Faculty of Veterinary Medicine, Mansoura University, Dakahlia 35516, Egypt.
7. Zoology and Entomology Department, Faculty of Science, Helwan University, Cairo 11795, Egypt.
- Publication Type:Journal Article
- Keywords:
Apoptosis;
Berberine;
Ehrlich solid tumor;
Oxidative stress;
Selenium nanoparticles
- MeSH:
Animals;
Antineoplastic Agents;
Antioxidants;
Berberine;
Male;
Mice;
Nanoparticles;
Selenium
- From:
Journal of Integrative Medicine
2022;20(1):65-72
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:The chemo-preventative and therapeutic properties of selenium nanoparticles (SeNPs) have been documented over recent decades and suggest the potential uses of SeNPs in medicine. Biogenic SeNPs have higher biocompatibility and stability than chemically synthesized nanoparticles, which enhances their medical applications, especially in the field of cancer therapy. This study evaluated the potential of green-synthetized SeNPs by using berberine (Ber) as an antitumor agent and elucidated the mechanism by which these molecules combat Ehrlich solid tumors (ESTs).
METHODS:SeNPs containing Ber (SeNPs-Ber) were synthesized using Ber and Na
RESULTS:Treatment with SeNPs-Ber significantly improved the survival rate and decreased the body weight and tumor size, compared to the EST group. SeNPs-Ber reduced oxidative stress in tumor tissue, as indicated by a decrease in the lipid peroxidation and nitric oxide levels and an increase in the glutathione levels. Moreover, SeNPs-Ber activated an apoptotic cascade in the tumor cells by downregulating the B-cell lymphoma 2 (Bcl-2) expression rate and upregulating the Bcl-2-associated X protein and caspase-3 expression rates. SeNPs-Ber also considerably improved the histopathological alterations in the developed tumor tissue, compared to the EST group.
CONCLUSION:Our study provides a new insight into the potential role of green-synthesized SeNPs by using Ber as a promising anticancer agent, these molecules could be used alone or as supplementary medication during chemotherapy.
